Groupe Nature acquires Winco

Groupe Nature has signed an agreement with Nicolas Watine, founder and CEO of Winco, to acquire his stake in the comany. It specializes in the distribution of health and cosmetic products in parapharmacies affiliated to supermarket chains. This acquisition strengthens Groupe Nature’s position as a multi-channel specialist in the distribution of organic health products.

Founded in 1997, Groupe Nature distributes organic health products, mainly food supplements and cosmetics, through organic specialty shops, pharmacies and online.

Also founded in 1997, Winco is a reference distributor in the French parapharmacy market.

Oaklins’ team in France advised Groupe Nature on the acquisition of Winco.

Service

M&A buy-side

Parties

“We are very proud to integrate Winco into our group and we thank the Oaklins personal care and nutrition team for its commitment and expertise in achieving this transaction, which will allow us to extend our distribution channels to the health food industry and to develop Winco’s health product offering into the organic sector.”

Laurent Ducrocq

CEO, Groupe Nature

Talk to the deal team

Ludovic Beaulieu

Senior Advisor

Paris, France
Oaklins France

View profile Get in touch

Related deals

MEDIK Hospital Design Group has been acquired by STERIS

Construction & Engineering Services | Healthcare

MEDIK Hospital Design Group has been acquired by STERIS

The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.

Learn more

bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG

Healthcare

bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG

Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.

Learn more

SLT has been acquired by Indutrade

Healthcare

SLT has been acquired by Indutrade

SLT S.r.l. has been acquired by Indutrade AB and will be integrated into the group’s life science business area. The transaction is Indutrade’s fifth acquisition in 2025 and is expected to have a marginally positive impact on the group’s earnings per share.

Learn more